News

  • ASTCT submitted comments on the CMS National Coverage Analysis for Chimeric Antigen Receptor (CAR) T-cell Therapy last week. The public comment period has closed, and we expect the final coverage determination to be released no later than May 17. To read ...

  • An updated set of CAR-T resource slides are now available to ASBMT members and non-members. These act as a resource to anyone in the cellular therapy field. The slides, created by the CAR-T Working Group, cover everything from the basics of immunology ...

  • Leading off this month are two big announcements for our policy and advocacy work going forward. First, as detailed here , we recently announced we're changing our name to the American Society for Transplantation and Cellular Therapy (ASTCT). We are ...

  • The American Society for Blood and Marrow Transplantation (ASBMT), newly named the American Society for Transplantation and Cellular Therapy (ASTCT), has carefully reviewed the recently released National Coverage Analysis for Chimeric Antigen Receptor ...

  • Created by the ASBMT Board of Directors because of concerns that clinical fellowship programs don't adequately cover the principles of research and how to take findings from the laboratory to the clinic, this course helps close the gap by addressing ...